日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinoma

肝移植是肝细胞癌患者生存期≥10年的主要决定因素。

Rezaee-Zavareh, Mohammad Saeid; Ahn, Joseph C; Kim, Hyunseok; Luu, Michael; Ayoub, Walid; Kuo, Alexander; Trivedi, Hirsh; Wang, Yun; Vipani, Aarshi; Todo, Tsuyoshi; Voidonikolas, Georgios; Steggerda, Justin A; Wisel, Steven A; Brennan, Todd V; Ferrone, Cristina; Kim, Irene K; Kosari, Kambiz; Nissen, Nicholas; Parikh, Neehar D; Singal, Amit G; Yang, Ju Dong

Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients

细胞外囊泡数字评分检测法用于评估肝细胞癌患者的治疗反应

Zhao, Chen; Lee, Yi-Te; Melehy, Andrew; Kim, Minhyung; Yang, Jacqueline Ziqian; Zhang, Ceng; Kim, Jina; Zhang, Ryan Y; Lee, Junseok; Kim, Hyoyong; Ju, Yong; Tsai, Yuan-Jen; Zhou, Xianghong Jasmine; Han, Steven-Huy B; Sadeghi, Saeed; Finn, Richard S; Saab, Sammy; Lu, David S; Chiang, Jason; Park, Jae-Ho; Brennan, Todd V; Wisel, Steven A; Alsudaney, Manaf; Kuo, Alexander; Ayoub, Walid S; Kim, Hyunseok; Trivedi, Hirsh D; Wang, Yun; Vipani, Aarshi; Kim, Irene K; Todo, Tsuyoshi; Steggerda, Justin A; Voidonikolas, Georgios; Kosari, Kambiz; Nissen, Nicholas N; Saouaf, Rola; Singal, Amit G; Sim, Myung Shin; Elashoff, David A; You, Sungyong; Agopian, Vatche G; Yang, Ju Dong; Tseng, Hsian-Rong; Zhu, Yazhen

Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma

免疫疗法后的根治性治疗可使肝细胞癌患者获得极佳的疗效

Choi, Gwang Hyeon; Kim, Hyun-Seok; Luu, Michael; Kuo, Alexander; Ayoub, Walid S; Trivedi, Hirsh; Wang, Yun; Vipani, Aarshi; Chen, Pin-Jung; Miles, Steven A; Kaymen, Emily A; Hendifar, Andrew; Todo, Tsuyoshi; Brennan, Todd V; Voidonikolas, Georgios; Wisel, Steven A; Steggerda, Justin; Ferrone, Cristina; Kosari, Kambiz; Nissen, Nicholas; Parikh, Neehar D; Singal, Amit G; Yang, Ju Dong

Back-table intra-arterial administration of C1 esterase inhibitor to deceased donor kidney allografts improves posttransplant allograft function: Results of a randomized double-blind placebo-controlled clinical trial.

对已故供体肾脏同种异体移植进行术前动脉内注射 C1 酯酶抑制剂可改善移植后同种异体移植功能:一项随机双盲安慰剂对照临床试验的结果

Huang Edmund, Ammerman Noriko, Vo Ashley, Hou Jean, Kumar Sanjeev, Badash Nicole, Falk Ben, Hernando Kathleen, Gillespie Matthew, Kim Irene K, Lim Kathlyn, Najjar Reiad, Peng Alice, Shin Bongha, Steggerda Justin A, Todo Tsuyoshi, Brennan Todd V, Voidonikolas Georgios, Wisel Steven A, Heeger Peter S, Jordan Stanley C

Impact of Donor Age on Graft Failure After Deceased Donor Liver Transplantation by Donor-Recipient Sex Combinations: An Analysis of the UNOS OPTN Database

供体年龄对已故供体肝移植术后移植物衰竭的影响(按供受者性别组合分析):基于UNOS OPTN数据库的分析

Han, Sangbin; Agopian, Vatche A; Steggerda, Justin A; Kim, Irene K; Sanford, Alison; Lee, Yi-Te; Kwon, Ji-Hye; Rhu, Jin Soo; Kim, Gaab Soo; Yang, Ju-Dong

Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study

MASLD患者转诊至肝移植后的结局:加州肝脏网络研究

Lim, Tiffany Y; Steggerda, Justin A; Trivedi, Hirsh; Luu, Michael; Vipani, Aarshi; Adjei, Michie A; Singh, Jasleen; Zhou, Kali; Kwong, Allison; Tincopa, Monica; Vodkin, Irine; Ajmera, Veeral; Mehta, Neil; Freise, Chris E; Yilma, Mignote; Hirose, Ryutaro; Kuo, Alexander; Wisel, Steven A

Organ Utilization Rates from Non-Ideal Donors for Solid Organ Transplant in the United States

美国非理想供体器官用于实体器官移植的器官利用率

Wisel, Steven A; Borja-Cacho, Daniel; Megna, Dominick; Adjei, Michie; Kim, Irene K; Steggerda, Justin A

Use of Machine Perfusion in the United States Increases Organ Utilization and Improves DCD Graft Survival in Liver Transplantation

在美国,使用机器灌注可提高器官利用率并改善肝移植中DCD供体器官的存活率。

Wisel, Steven A; Steggerda, Justin A; Kim, Irene K

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis

更正:非酒精性脂肪肝疾病和非酒精性脂肪性肝炎中肝细胞因子、星状细胞因子、肌细胞因子和脂肪因子的调控网络及相互作用

Yang, Bing; Lu, Liqing; Zhou, Dongmei; Fan, Wei; Barbier-Torres, Lucía; Steggerda, Justin; Yang, Heping; Yang, Xi

CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression.

CSNK2A1介导的MAX磷酸化上调胆管癌进展中的HMGB1和IL-6表达

Yang Bing, Zhang Jing, Wang Jiaohong, Fan Wei, Barbier-Torres Lucía, Yang Xi, Justo Monica Anne R, Liu Ting, Chen Yongheng, Steggerda Justin, Ramani Komal, Lu Shelly C, Yang Heping